Latigo Biotherapeutics
Clinical trials sponsored by Latigo Biotherapeutics, explained in plain language.
-
New painkiller shows promise for tummy tuck recovery
Symptom relief CompletedThis study tested a new drug called LTG-001 to see if it can safely reduce pain after a tummy tuck (abdominoplasty). 343 adults took the drug or a placebo for 48 hours after surgery and reported their pain levels. The goal was to find the best dose for pain relief and to see if i…
Phase: PHASE2 • Sponsor: Latigo Biotherapeutics • Aim: Symptom relief
Last updated May 26, 2026 03:23 UTC
-
New pain drug shows promise for post-surgery relief in completed trial
Symptom relief CompletedThis study tested whether a single dose of LTG 001 can safely reduce pain after wisdom tooth removal. About 250 adults took the drug or a placebo and reported their pain levels over 12 hours. The goal was to see if LTG 001 provides faster and more effective pain relief than a dum…
Phase: PHASE2 • Sponsor: Latigo Biotherapeutics • Aim: Symptom relief
Last updated May 26, 2026 03:11 UTC
-
Healthy volunteers help test new pain pill absorption
Knowledge-focused CompletedThis study involved 14 healthy adults to compare how quickly and completely two different tablet forms of an experimental pain drug (LTG-001) are absorbed by the body. The goal was to see if a new formulation works better than the original. No treatment was given for pain; the st…
Phase: PHASE1 • Sponsor: Latigo Biotherapeutics • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC